Related references
Note: Only part of the references are listed.Pretreatment with Statin Attenuates the Cardiotoxicity of Doxorubicin in Mice
Alexander Riad et al.
CANCER RESEARCH (2009)
Cardiac-Targeted Expression of Soluble Fas Attenuates Doxorubicin-Induced Cardiotoxicity in Mice
Jianli Niu et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Role of the peroxynitrite-poly(ADP-ribose) polymerase pathway in human disease
Pal Pacher et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
ERKs/p53 signal transduction pathway is involved in doxorubicin-induced apoptosis in H9c2 cells and cardiomyocytes
Jiahao Liu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2008)
Molecular mechanisms of angiotensin II-mediated mitochondrial dysfunction - Linking mitochondrial oxidative damage and vascular endothelial dysfunction
Abdulrahman K. Doughan et al.
CIRCULATION RESEARCH (2008)
Paradoxical effect of diphenyleneiodonium in inducing DNA damage and apoptosis
Jennifer M. Longpre et al.
FREE RADICAL RESEARCH (2008)
Oxidative inactivation of key mitochondrial proteins leads to dysfunction and injury in hepatic ischemia reperfusion
Kwan-Hoon Moon et al.
GASTROENTEROLOGY (2008)
Measurement of cardiac function using pressure-volume conductance catheter technique in mice and rats
Pal Pacher et al.
NATURE PROTOCOLS (2008)
Pivotal Advance:: Cannabinoid-2 receptor agonist HU-308 protects against hepatic ischemia/reperfusion injury by attenuating oxidative stress, inflammatory response, and apoptosis
Mohanraj Rajesh et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
Pharmacological inhibition of CB1 cannabinoid raceptor protects against doxorubicin-induced cardiotoxicity
Partha Mukhopadhyay et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Decreased age-related cardiac dysfunction, myocardial nitrative stress, inflammatory gene expression, and apoptosis in mice lacking fatty acid amide hydrolase
Sandor Batkai et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
Disruption of nitric oxide synthase 3 protects against the cardiac injury, dysfunction, and mortality induced by doxorubicin
Tomas G. Neilan et al.
CIRCULATION (2007)
Simple quantitative detection of mitochondrial superoxide production in live cells
Partha Mukhopadhyay et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Cannabinoid-2 receptor mediates protection against hepatic ischemia/reperfusion injury
Sandor Batkai et al.
FASEB JOURNAL (2007)
Acute doxorubicin cardiotoxicity is successfully treated with the phytochemical oleuropein through suppression of oxidative and nitrosative stress
Ioanna Andreadou et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2007)
Simultaneous detection of apoptosis and mitochondrial superoxide production in live cells by flow cytometry and confocal microscopy
Partha Mukhopadhyay et al.
NATURE PROTOCOLS (2007)
Nitric oxide and peroxynitrite in health and disease
Pal Pacher et al.
PHYSIOLOGICAL REVIEWS (2007)
Role of Poly(ADP-ribose) polymerase 1 (PARP-1) in cardiovascular diseases: The therapeutic potential of PARP inhibitors
Pal Pacher et al.
CARDIOVASCULAR DRUG REVIEWS (2007)
Increase in Mrp1 expression and 4-hydroxy-2-nonenal adduction in heart tissue of adriamycin-treated C57BL/6 mice
Paiboon Jungsuwadee et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Peroxynitrite is a major trigger of cardiomyocyte apoptosis in vitro and in vivo
Sandra Levrand et al.
FREE RADICAL BIOLOGY AND MEDICINE (2006)
Tissue Doppler imaging predicts left ventricular dysfunction and mortality in a murine model of cardiac injury
Tomas G. Neilan et al.
EUROPEAN HEART JOURNAL (2006)
Discovery of bioactive small-molecule inhibitor of poly ADP-ribose polymerase: Implications for energy-deficient cells
Stephen M. Altmann et al.
CHEMISTRY & BIOLOGY (2006)
An osteopontin-NADPH oxidase signaling cascade promotes pro-matrix metalloproteinase 9 activation in aortic mesenchymal cells
Chung-Fang Lai et al.
CIRCULATION RESEARCH (2006)
Increased activity of the ubiquitin-proteasome system in patients with symptomatic carotid disease is associated with enhanced inflammation and may destabilize the atherosclerotic plaque - Effects of rosiglitazone treatment
Raffaele Marfella et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Doxorubicin induces apoptosis by activation of caspase-3 in cultured cardiomyocytes in vitro and rat cardiac ventricles in vivo
Michihiko Ueno et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2006)
Thrombopoietin protects against in vitro and in vivo cardiotoxicity induced by doxorubicin
K Li et al.
CIRCULATION (2006)
Enhanced gene expression of myocardial matrix metalloproteinases 2 and 9 after acute treatment with doxorubicin in mice
K Kizaki et al.
PHARMACOLOGICAL RESEARCH (2006)
Beneficial role of aminoguanidine on acute cardiomyopathy related to doxorubicin-treatment
Yilmaz Cigremis et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2006)
Matrix metalloproteinase-2 and-9 are induced differently by doxorubicin in H9c2 cells: The role of MAP kinases and NAD(P)H oxidase
P Spallarossa et al.
CARDIOVASCULAR RESEARCH (2006)
The protective roles of nitric oxide and superoxide dismutase in adriamycin-induced cardiotoxicity
MP Cole et al.
CARDIOVASCULAR RESEARCH (2006)
Antioxidant mechanism of heme oxygenase-1 involves an increase in superoxide dismutase and catalase in experimental diabetes
S Turkseven et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2005)
Nitrosative stress and pharmacological modulation of heart failure
P Pacher et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2005)
Peroxynitrite activates ERK via Raf-1 and MEK, independently from EGF receptor and p21Ras in H9C2 cardiomyocytes
B Pesse et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2005)
Poly(ADP-ribose) polymerase regulates myocardial calcium handling in doxorubicin-induced heart failure
O Szenczi et al.
BIOCHEMICAL PHARMACOLOGY (2005)
Malondialdehyde, glutathione, glutathione peroxidase and homocysteine levels in type 2 diabetic patients with and without microalbuminuria
G Ozdemir et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2005)
Cyclooxygenase-2 inhibitor treatment improves left ventricular function and mortality in a murine model of doxorubicin-induced heart failure
RM Delgado et al.
CIRCULATION (2004)
Oxidative damage precedes nitrative damage in adriamycin-induced cardiac mitochondrial injury
L Chaiswing et al.
TOXICOLOGIC PATHOLOGY (2004)
Modulation of doxorubicin-induced cardiac dysfunction in Toll-like receptor-2-knockout mice
N Nozaki et al.
CIRCULATION (2004)
Potent metalloporphyrin peroxynitrite decomposition catalyst protects against the development of doxorubicin-induced cardiac dysfunction
P Pacher et al.
CIRCULATION (2003)
Nitric oxide, superoxide, and peroxynitrite in myocardial ischaemia-reperfusion injury and preconditioning
P Ferdinandy et al.
BRITISH JOURNAL OF PHARMACOLOGY (2003)
Peroxynitrite reactions and formation in mitochondria
R Radi et al.
FREE RADICAL BIOLOGY AND MEDICINE (2002)
Activation of nuclear factor-κB during doxorubicin-induced apoptosis in endothelial cells and myocytes is pro-apoptotic:: the role of hydrogen peroxide
SW Wang et al.
BIOCHEMICAL JOURNAL (2002)
Intracellular distribution of peroxynitrite during doxorubicin cardiomyopathy: evidence for selective impairment of myofibrillar creatine kinase
MJ Mihm et al.
BRITISH JOURNAL OF PHARMACOLOGY (2002)
Activation of poly(ADP-ribose) polymerase contributes to development of doxorubicin-induced heart failure
P Pacher et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Propagation of the apoptotic signal by mitochondrial waves
P Pacher et al.
EMBO JOURNAL (2001)
Apoptosis in adriamycin cardiomyopathy and its modulation by probucol
D Kumar et al.
ANTIOXIDANTS & REDOX SIGNALING (2001)
Adriamycin-induced heart failure: mechanisms and modulation
P Singal et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2000)
Share Paper
